Novartis plots more than 100 layoffs in New Jersey as part of rework to Xolair, cancer combo field sales teams
While Novartis has largely wrapped up its transformation into a leaner innovative medicines company—which included multiple rounds of staff cuts over the years—employment changes are still afoot at the Swiss pharma giant. Take, for instance, a fresh round …